| pubmed-article:19378678 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19378678 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19378678 | lifeskim:mentions | umls-concept:C0242656 | lld:lifeskim |
| pubmed-article:19378678 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:19378678 | lifeskim:mentions | umls-concept:C0681698 | lld:lifeskim |
| pubmed-article:19378678 | lifeskim:mentions | umls-concept:C1414461 | lld:lifeskim |
| pubmed-article:19378678 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:19378678 | lifeskim:mentions | umls-concept:C1322815 | lld:lifeskim |
| pubmed-article:19378678 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19378678 | pubmed:dateCreated | 2009-4-21 | lld:pubmed |
| pubmed-article:19378678 | pubmed:abstractText | To determine whether repeat revascularisation (RR) in diabetic patients treated with prior drug-eluting stents (DES) is the result of either DES restenosis or native progression of atherosclerotic disease in the coronary vasculature, and to evaluate the impact of atherosclerotic disease progression on the midterm clinical outcome. | lld:pubmed |
| pubmed-article:19378678 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19378678 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19378678 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19378678 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19378678 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:19378678 | pubmed:issn | 1774-024X | lld:pubmed |
| pubmed-article:19378678 | pubmed:author | pubmed-author:FajadetJeanJ | lld:pubmed |
| pubmed-article:19378678 | pubmed:author | pubmed-author:FarahBrunoB | lld:pubmed |
| pubmed-article:19378678 | pubmed:author | pubmed-author:OregliaJacopo... | lld:pubmed |
| pubmed-article:19378678 | pubmed:author | pubmed-author:TousekPetrP | lld:pubmed |
| pubmed-article:19378678 | pubmed:author | pubmed-author:MartinGuillau... | lld:pubmed |
| pubmed-article:19378678 | pubmed:author | pubmed-author:PaveiAndreaA | lld:pubmed |
| pubmed-article:19378678 | pubmed:author | pubmed-author:SharifFaisalF | lld:pubmed |
| pubmed-article:19378678 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19378678 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:19378678 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19378678 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19378678 | pubmed:pagination | 588-92 | lld:pubmed |
| pubmed-article:19378678 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:meshHeading | pubmed-meshheading:19378678... | lld:pubmed |
| pubmed-article:19378678 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19378678 | pubmed:articleTitle | Impact of atherosclerotic disease progression on mid-term clinical outcome in diabetic patients in the drug-eluting stent era. | lld:pubmed |
| pubmed-article:19378678 | pubmed:affiliation | Cardiocenter, Third Faculty of Medicine, Charles University, Ruska 87, 10000 Prague, Czech Republic. tousek@email.cz | lld:pubmed |
| pubmed-article:19378678 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19378678 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
